Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) — Clinical Trial Site

689 Registered trials

302 Currently recruiting

Organisation

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Location

Rotterdam, Netherlands

Identifier

ORG-100008976

Address

Wytemaweg 80, 3015 CN, Netherlands

Departments

-
#1704:Cardiology
#1801: Department of Internal Medicine
#2050:Internal Medicine
#3302:Internal Medicine
#3353:Cardiology
#3401: Department of pediatric dermatology
#40264: Dermatology
#5001: Immunology and Rheumatology
#5001:Dermatology
#6002:Neurology
02-044:Hematologie
2061 : Neurology
2401: Dermatology
2502: Hematology
2802:Internal Medicine
3000: Oncologie
3401: Medical Oncology
461: Internal Medicine
5001:Cardiology
528001; Hematology, Transfusion Medicine
52801: Endocrinology
52802: ophthalmology
7001: Pulmonary Department
7012: Dermatology
Afdeling hematologie
Afdeling kindernefrologie, kamer Sp- 2430
Afdeling Longgeneeskunde
Afdeling Oncologie
Allergology Dep.
Anaesthesia
Anesthesiology
Arends
Cancer Center
Cancer Institute
Cardiology
Cardiology and Radiology & Nuclear Medicine
Center for lysosomal and matabolic diseases and porphyria center
Center for Lysosomal and Metabolic Diseases
Centre for internal lung diseases
Centre for lysosomal and metabolic disease, Paediatrics
Children Gastroenterology and Hepatology
Children Rheumatology
Clinical Immunology
Dep of Hematology - Centrumlocation
Dep of Rheumatology and Clinical Immunology
Department Internal Medicine
Department of Anesthesiology
Department of Cardiology
Department of dermatology
Department of Gastroenterology & hepatology
Department of Gastroenterology and Hepatology
Department of Hematology
Department of Hematology, office Na 810
Department of Hospital Pharmacy
Department of ILD
Department of Intensive Care
Department of Internal Medicine
Department of Internal Oncology
Department of Medical Oncology
Department of Nephrology
Department of Neuro-Oncology
Department of Neurology
Department of Neurology Nf329
Department of Neurology, sub-department of Pediatric Neurology
Department of Neurosurgery
Department of Orthopaedics and Sports Medicine
Department of Otorhinolaryngology, Head & Neck Surgery
Department of Pediatric Lung Diseases/division of Paediatric Respiratory Medicine and Allergology
Department of Pediatric Respiratory Medicine
Department of Pediatrics
Department of Pediatrics, division of Respiratory Medicine and Allergology
Department of Pulmonary Diseases
Department of Pulmonary Science
Department of pulmonology
Department of Surgery
Department of Surgical Oncology
Department Otorhinolaryngology, Head and Neck Surgery
Dept of Cardiology
dept of internal oncology
Dept of Medical Oncology
Dept of Pediatrics, Div. of Metabolic Diseases and Genetics
Dept. Dermatology
Dept. Gastroenterology and Hepatology
Dept. of Pediatric Respiratory Medicine
Dept. of Viroscience
Dermatology
Dermatology department
Dpt of Medical Oncology
EMCR, Section Immunology, Department of internal Medicine
Endocrinologie
Endocrinology
Erasmus MC
Erasmus MC_LOC#1
Erasmus MC, Dermatologie
Erasmus Medical Center
Erasmus Medisch Centrum
Erasmus Medisch Centrum( #1)
gastroenterology
Gastroenterology & Hepatology
Gastroenterology and Hepatology
Gastroentology
General practice
General Surgery
Gynaecologic oncology
Gynaecologische Oncologie
Gynecology and obstetrics
Haematology
Head and Neck surgery
Head and Neck surgery and otorhinolaryngology
Head- and Neck Surgery and Oncology
Heelkunde
Hematologie
Hematology
Hematology Department
Hepato-Pancreato-Biliair Chirurg en Chirurgisch Oncoloog
IC Neonatology
ICU
Immunology
Infectious Disease
Intensive Care
Intensive Care and Cardiology
Internal Hematologist
Internal Medicine
Internal Medicine / Oncology
Internal Medicine-Infectious Diseases
Internal Medicine-Nephrology
Internal Medicine, division Immunology
Internal medicine, Infectious disease
Internal Oncology
Interne geneeskunde
Interne Oncologie
Interne Oncologie / Medical Oncology
Interne oncology
Interstitial lung diseases
Inwendige Geneeskunde
Kindergeneeskunde
Klinische Immunologie,
Long Oncology
Longgeneeskunde
Longoncologie
Longziekten
Lung department
Lung Disease
Lung oncology
MDL
Medical Oncology
Medical Oncology and Radiology & Nuclear Medicine
Medical Oncology and Radiology and Nuclear Medicine
Medische Oncologie
N-A
N/A
NA
Na-823, Secretariaat Hematologie
Nefrologie
Neonatology
Nephrology
Nephrology Department
Neuro Oncology
Neuro-oncology
Neurologie
Neurology
Neurology and intensive care
Neurosurgery
NL10004, Gastroenterology and Hepatology
NL10006: Gastroenterology and Hepatology
NL10006: Hematology,Transfusion Medicine
NL10011, Gastroenterology and Hepatology
NLD001:Pulmonology
Not applicable
Oncologie
Oncology
Oncology and Radiology & Nuclear Medicine
Oncology and Radiology and Nuclear Medicine
Ophthalmology
ORL-Heas Neck Surgery
Orthopaedics & Sports Medicine
orthopedics
Orthopedics and Sports Medicine
Paediatric Gastroenterology
Paediatrics
Pediaetric neurology
Pediatric Gastroenterology
Pediatric Hematology
Pediatric Neurology
Pediatric Surgery
Pediatrics
Pediatrics, Center for Lysosomal and Metabolic Disease
Pediatrics, Center for Lysosomal and Metabolic Disaeses
Pharmacy
Pharmacy and Internal Medicine
Pulmanory Medicine Department
Pulmology
Pulmonary
Pulmonary Department
Pulmonary Disease
Pulmonary Diseases
Pulmonary medicine
Pulmonary Science
Pulmonology
Radiologie en Nucleaire Geneeskunde
Radiology
Radiology & Nuclear Medicine
Radiology and Nuclear Medicine
Radiotherapy
Research Department Pulmonary Disease
Research Facility
Research Longziekten
Respiratory Medicine
Reumatologie
Rg5 Erasmus MC
Rheumatology
Sophia Children´s Hospital
Sophia Children's Hospital, department of pediatric hematology & oncology
Sophia kinderziekenhuis
Sophia-Kindergeneeskunde
Surgery
Surgical oncology
t Neuro-Oncology Unit
t.a.v. trialmagazijn, Nc-216 METC nr: R22.082
TBC
Thoracale Oncologie
Thoraxoncology
Trialbureau kinderoncologie
Urology
Verloskunde & Gynaecologie
Viroscience Department
Z97NL10001: Hematology

Clinical trials at this site (689)

Search interface

Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Subjects With Progressive Metastatic Castration-… Ended

2024-513968-25-00 Metastatic castration-resistant prostate cancer (mCRPC) 5 2025-04-28
A Study of the Efficacy and Safety of Efgartigimod in Patients with Primary Sjögren's Syndrome (pSjD) (UNITY) Ended

2024-516609-22-00 Primary Sjögren’s Disease 5 2025-04-15
A Phase 1b/2, multicenter study of vorasidenib in combination with temozolomide (TMZ) in participants with IDH1- or IDH2-mutant glioma Ended

2024-513738-39-00 IDH1-mutant Glioma 9 2025-03-18
Melatonin for patients with chronic low back pain - a randomized placebo-controlled trial Ended

2024-514769-20-00 Chronic low back pain 5 2025-03-02
An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants with Chronic Thyroid Eye Disease (TED) Ended

2024-514973-23-00 Thyroid eye disease 5 2025-02-25
Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer Ended

2024-512998-27-00 Non-Small Cell Lung Cancer 5 2025-02-21
HOVON 172 MF: Study on tasquinimod treatment in patients with myelofibrosis Ended

2024-511565-11-00 Myelofibrosis 9 2025-02-12
A study to test an oral medicine, belumosudil, in combination with corticosteroids in participants at least 12 years of age with newly diagn… Ended

2023-505394-32-00 chronic graft versus host disease 5 2025-02-06
A Study to Investigate the Efficacy and Safety of Solrikitug in Adults with Eosinophilic Esophagitis Ended

2024-510849-34-00 Eosinophilic Esophagitis 4 2025-02-04
A clinical trial to learn about the effects of YTB323 in people with difficult-to-treat severe inflammatory myopathies (IIM) Ended

2024-514137-38-00 Severe refractory idiopathic inflammatory myopathies (I 4 2025-02-04
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women with Breast Cancer Who Are Having Hormone Therapy Ended

2024-510719-31-00 Moderate to Severe Vasomotor Symptoms (VMS) 5 2025-01-24
Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis Subjects 12 Months of Age and Older Ended

2023-509563-24-00 Cystic Fibrosis 5 2025-01-08
Efficacy and Safety of Anitocabtagene Autoleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Multiple Myeloma Ended

2024-511188-26-00 Relapsed/refractory multiple myeloma in patients who ha 5 2024-12-20
Hidradenitis Suppurativa: Evaluation of lutikizumab in Adult and Adolescent Subjects Ended

2024-510730-40-00 Hidradenitis Suppurativa 5 2024-12-12
Efficacy and safety study of frexalimab (SAR441344) in adults with nonrelapsing secondary progressive multiple sclerosis Ended

2023-504359-29-01 Multiple sclerosis 5 2024-12-11
The goal of this clinical study is to learn more about the safety and dosing of the study drugs, KITE-363 and KITE-753, in participants with… Ended

2024-511616-24-00 Relapsed and/or Refractory B-cell Lymphoma 1 2024-12-06
Prevention of the return of nephrotic syndrom in children by adding levamisole to prednisolone treatment Ended

2024-517467-23-00 steroid sensitive idiopathic nephrotic syndrome 5 2024-11-29
Study Comparing Tarlatamab and Durvalumab versus Durvalumab Alone in First Line ES-SCLC Following Platinum, Etoposide and Durvalumab (DeLLph… Ended

2023-505989-29-00 Extensive stage small cell lung cancer (ES-SCLC) 5 2024-11-21
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL593 in Healthy Participants and Participants with… Ended

2023-508697-28-00 Frontotemporal Dementia (FTD) 7 2024-11-13
A Randomized Clinical Trial Investigating Olaparib, Durvalumab (MEDI4736) and UV1 as Maintenance Therapy in BRCAwt Patients with Recurrent O… Ended

2024-516327-14-00 Ovarian cancer 4 2024-11-13
GenePHIT: A study to learn more about how well a new gene therapy (AB-1002) works and its safety in participants with congestive heart failu… Ended

2024-510581-17-00 Adult subjects with New York Heart Association (NYHA) C 4 2024-11-05
A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008) Ended

2023-508636-61-00 Crohn’s Disease 5 2024-10-24
CIAO@TBI Ended

2024-514488-24-02 Traumatic Brain Injury 4 2024-10-09
Comparing the effectiveness of our tailor-made management approach with routine care from a clinical, patient's as well as an economic point… Ended

2024-511530-12-01 Rheumatoid arthritis according to 2010 criteria 6 2024-10-01